AI assistant
Sending…
EXACT SCIENCES CORP — Director's Dealing 2013
Jul 29, 2013
30597_dirs_2013-07-29_d9239c97-382c-4d42-ad40-78fe29f8c7a2.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: EXACT SCIENCES CORP (EXAS)
CIK: 0001124140
Period of Report: 2013-07-25
Reporting Person: LIDGARD GRAHAM PETER (Sr. VP, Chief Science Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2013-04-30 | Common Stock | A | 764 | $7.81 | Acquired | 102633 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2013-07-25 | Restricted Stock Units | $ | A | 75000 | Acquired | Common Stock (75000) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 9748 | Indirect |
Footnotes
F1: Represents shares purchased through Employee Stock Purchase Plan.
F2: Each restricted stock unit represents a contingent right to receive one share of common stock.
F3: These restricted stock units vest in three equal annual installments beginning on the first anniversary of the grant date.
More from EXACT SCIENCES CORP
Major Shareholding Notification
2026
Mar 26
Regulatory Filings
2026
Mar 23
Regulatory Filings
2026
Mar 23
Regulatory Filings
2026
Mar 23
Regulatory Filings
2026
Mar 23
Regulatory Filings
2026
Mar 23
Regulatory Filings
2026
Mar 23
Regulatory Filings
2026
Mar 23
Regulatory Filings
2026
Mar 23
Regulatory Filings
2026
Mar 23